- cafead Jun 18, 2018 at 10:02: AM
via Valeant Pharmaceuticals International said on Monday that U.S. health regulators had declined to approve its lotion to treat plaque psoriasis.
article source
article source
-
Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page
Valeant shares drop 5% after FDA fails to approve plaque psoriasis lotion
- Thread starter cafead
- Start date
<
Similar threads